| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/15/2009 | CN100513563C Wt1-origin HLA-DR-binding antigen peptide |
| 07/15/2009 | CN100513558C ARCELIN-5 promoter and uses thereof |
| 07/15/2009 | CN100513550C High effect chitin degradation bacteria cavy aeromon spore bacteria and its produced chitinase |
| 07/15/2009 | CN100513548C Improved methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms |
| 07/15/2009 | CN100513420C Fe(II) transfer protein of crabapple and its coding gene and use |
| 07/15/2009 | CN100513414C A system for antibody expression and assembly |
| 07/15/2009 | CA2613026A1 Added new stem cells processes/methods/techniques |
| 07/14/2009 | US7560626 Promoter sequence obtained from rice and methods of use |
| 07/14/2009 | US7560623 Enzymatic methods for modulating the levels of organic sulfur compounds in plants |
| 07/14/2009 | US7560622 Generating transgenic plant; obtain cell, transform, propagate, monitor gene expression |
| 07/14/2009 | US7560621 Soybean cultivar S07-03JR108674 |
| 07/14/2009 | US7560620 Soybean cultivar S07-03KL016279 |
| 07/14/2009 | US7560617 Soybean variety D4253854 |
| 07/14/2009 | US7560616 Soybean cultivar 6012078 |
| 07/14/2009 | US7560615 Comprises isolated isoflavone synthase 1 (IFS1) promoter nucleic acids; use in directing transcription of transgenes in plants |
| 07/14/2009 | US7560613 Comprises nucleotide sequences coding trehalose-6-phosphate phosphatase for enhancing water stress tolerance in plants; tissue engineering |
| 07/14/2009 | US7560612 For regulatory elements providing expression preferentially in the inflorescence meristem and developing floral tissues; Comprises nucleotide sequences associated with controlling flowering and tissue specific expression of heterologous proteins during flower development |
| 07/14/2009 | US7560611 Method and apparatus for substantially isolating plant tissues |
| 07/14/2009 | US7560610 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 07/14/2009 | US7560543 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 07/14/2009 | US7560542 Expression vector comprising nucleotide sequences coding plant transcription factors; improving heterologous gene expression in crops; Expressed Sequence Tags (ESTs) isolated from maize |
| 07/14/2009 | US7560541 Heart20049410 full-length cDNA and polypeptides |
| 07/14/2009 | US7560540 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 07/14/2009 | US7560539 PUFA polyketide synthase systems and uses thereof |
| 07/14/2009 | US7560538 Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | US7560439 Method for increasing the gene expression of transfected genes |
| 07/14/2009 | US7560438 Genetic inhibition by double-stranded RNA |
| 07/14/2009 | US7560437 Therapeutic agent for use in the diagnosis and treatment of cancer and cell proliferative disorders |
| 07/14/2009 | US7560424 Localize to a specific subcellular compartment such as the lysosome are provided. The targeted therapeutics include a therapeutic agent and a targeting moiety that binds a receptor on an exterior surface of the cell, permitting proper |
| 07/14/2009 | US7560290 Determining in a sample from the diabetic patient presence of a polypeptide comprising (Thrombin-Activable Fibrinolysis Inhibitor, TAFI); stroke, transitory ischemic attack, atherosclerotic cerebrovascular disease and/or coronary heart disease; cardiovascular disorders |
| 07/14/2009 | US7560287 Long wavelength engineered fluorescent proteins |
| 07/14/2009 | US7560282 System for the internal qualitative and quantitative validation of marker indices |
| 07/14/2009 | US7560281 Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells |
| 07/14/2009 | US7560278 A recombinant mammalian cell that expresses a mammalian adenovirus E1 functional protein and comprises a porcine circovirus genome |
| 07/14/2009 | US7560273 Slip cover for heated platen assembly |
| 07/14/2009 | US7560268 Supressing spreading or bleeding of a probe solution on a substrate and fix DNA probes, a biochip with probe regions arranged at a high density can be manufactured easily |
| 07/14/2009 | US7560265 Compositions for regulation of tumor necrosis factor-alpha |
| 07/14/2009 | US7560264 Inducing transcription of cloned DNA in cultures; bioreactors and heterologous gene expression |
| 07/14/2009 | US7560262 Polynucleotide sequences encoding alkaline α-galactosidases and methods of using same |
| 07/14/2009 | US7560261 Nucleic acid sequences encoding CEL II endonuclease |
| 07/14/2009 | US7560259 Transferase for use as evaluative tool in diagnosing/prediciting cell proliferative, neurodegenerative and arsenic metabolism disorders |
| 07/14/2009 | US7560253 Detecting level of expression of a hemopoietic linkage switch-5 (HLS-5) polynucleotide in a biological sample from a suspected or known cancer patient |
| 07/14/2009 | US7560252 Borrelidin-producing polyketide synthase and its use |
| 07/14/2009 | US7560250 comprise a large heterologous polypeptide, such as a membrane protein, fused to a small soluble carrier polypeptide, which can be expressed by recombinant host cells in amounts and with solubility, purifiability and stability under crystallization conditions enabling their high-grade crystallization |
| 07/14/2009 | US7560249 The substrate comprises a carbon source comprising ethanol and an inducer |
| 07/14/2009 | US7560248 Oxidation-resistant ribonuclease inhibitor |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560245 Luciferase and methods for measuring intracellular ATP using the same |
| 07/14/2009 | US7560235 Method of detecting reaction of DNA and DNA-binding protein |
| 07/14/2009 | US7560234 Use of a gene expressed by fungal cells producing ochratoxin A in the detection and/or identification of ochratoxigenic fungi; Aspergillus ochraceus |
| 07/14/2009 | US7560232 Methods of capturing, detecting and quantifying RNA:DNA hybrids and a modified RNase H useful therein |
| 07/14/2009 | US7560228 Extracting nucleotide sequences from matrix immobilized eukaryotic and/or prokaryotic cells for diagnosing microbial infections, forensic identification, tissue and blood typing and detecting genetic variation |
| 07/14/2009 | US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 07/14/2009 | US7560108 Anti-TNFα antibodies |
| 07/14/2009 | US7560107 Antihemophilic factor for use in the treatment of blood disorders; corrects hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII |
| 07/14/2009 | US7560106 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 07/14/2009 | US7560101 Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A |
| 07/14/2009 | CA2468755C Resistance circuit stabilization and pulse duration control systems for electroporation instruments |
| 07/14/2009 | CA2392009C Magnetic glass particles, method for their preparation and uses thereof |
| 07/14/2009 | CA2385766C Methods for production of proteins in host cells |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2242542C Compositions and methods for therapeutic use |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/14/2009 | CA2158485C Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
| 07/14/2009 | CA2133554C Synthesis of diverse and useful collections of oligonucleotides |
| 07/14/2009 | CA2114357C Biological screens for detection of herbicides |
| 07/10/2009 | CA2617691A1 Translocator component derivatives and uses thereof |
| 07/09/2009 | WO2009086352A2 Cynomolgus toll-like receptor 3 |
| 07/09/2009 | WO2009086229A2 Drought tolerant plants and related constructs and methods involving genes encoding mir827 |
| 07/09/2009 | WO2009086215A2 Pathway analysis of cell culture phenotypes and uses thereof |
| 07/09/2009 | WO2009086156A2 Mir-10 regulated genes and pathways as targets for therapeutic intervention |
| 07/09/2009 | WO2009086086A1 Directed complementation with removable gene of interest |
| 07/09/2009 | WO2009086075A1 Improved strain for butanol production |
| 07/09/2009 | WO2009086000A2 Biomarkers for trichogenicity |
| 07/09/2009 | WO2009085982A1 Method to enhance yield and purity of hybrid crops |
| 07/09/2009 | WO2009085953A2 Ketol-acid reductoisomerase using nadh |
| 07/09/2009 | WO2009085935A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | WO2009085868A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | WO2009085278A1 Methods and compositions for producing olefins |
| 07/09/2009 | WO2009085277A2 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| 07/09/2009 | WO2009085275A2 Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions |
| 07/09/2009 | WO2009085274A2 Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars |
| 07/09/2009 | WO2009085273A2 Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
| 07/09/2009 | WO2009085271A2 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions |
| 07/09/2009 | WO2009085270A2 Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions |
| 07/09/2009 | WO2009085269A2 Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| 07/09/2009 | WO2009085268A2 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions |
| 07/09/2009 | WO2009085172A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 07/09/2009 | WO2009084999A1 Woody plants having improved growth charateristics and method for making the same using transcription factors |
| 07/09/2009 | WO2009084753A1 Mutation of prps1 gene causing cmtx5 disease and the use thereof |
| 07/09/2009 | WO2009084740A1 Method and composition for predicting the postsurgical recurrence in patient suffering from pulmonary adenocarcinoma |
| 07/09/2009 | WO2009084694A1 Method for prediction about carcinogenicity of substance in rodent |
| 07/09/2009 | WO2009084680A1 Gold nanoparticle composition, dna chip, near infrared absorbent, drug carrier for drug delivery system (dds), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084668A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method |